ArticleDiscover oncology2025

PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.